The Innovation and Value Initiative Appoints Dr. Jason Spangler as Incoming CEO

IVI CEO Jason SpanglerWashington D.C. (July 21, 2022) –The Innovation and Value Initiative (IVI) recently announced Dr. Jason Spangler as their incoming Chief Executive Officer, effective July 25, 2022. For nearly two decades Dr. Spangler has worked in professional health policy and public health sector with extensive experience with pharmaceutical and nonprofit organizations. Dr. Spangler joins IVI from his most recent role as Executive Medical Director, Global HTA Policy Strategy & Engagement for Amgen, Inc.

Dr. Spangler earned his MD at the Pennsylvania State University College of Medicine in 1998 and his Master of Public Health from the Johns Hopkins Bloomberg School of Public Health in 2002. His commitment to public health, preventative medicine, and health equity date back to his medical school residency, during which he served as a medical team leader for free clinics in Costa Rica, a resident coordinator for free clinics for homeless around UPMC, and a clinical educator in the International Medical Corps in Kosovo.

After serving one year as Chief Resident, Dr. Spangler joined Pfizer Global Pharmaceuticals as a Public Health and Health Policy Consultant. He remained in this role for three year and then moved on to the Partnership for Prevention, where he started as a Managing Senior Fellow and was promoted to Chief Medical Officer until he was recruited to Amgen.

About IVI  

The Innovation and Value Initiative Foundation, Inc. (IVI) is a 501(c)(3) nonprofit research organization whose mission is advancing the science of value assessment in healthcare. IVI is a membership organization with both organizational and individual members. Founded in late 2016 as a project by academics associated with Precision Health Economics, IVI sought to influence health economics and outcomes research thinkers, academics, and value assessors through policy papers, commentary, and events that made the case for novel approaches to value assessment methodologies. In 2018, IVI published its first Open-Source Value Project (OSVP) model addressing Rheumatoid Arthritis, the same year that it began to transition to a nonprofit entity.

IVI raises the level of discussion of value in healthcare and works to find common ground in approaches to measuring value through research, method development, scientific communication, and engagement. The US health system is diverse, complex, and ripe for innovation in the value space, and IVI is uniquely positioned to challenge outdated thinking and methodologies and provide a learning lab to co-create solutions.

About SMA

Sterling Martin Associates is a leading, specialty national search firm conducting chief executive-level searches for associations and nonprofit organizations. SMA has built an outstanding reputation by providing impeccable service to clients and by placing exceptional talent in associations and nonprofits. Based in Washington, DC, SMA has offices in New York, Chicago, Orange County, CA, and Portland, OR.

Founding the firm in 2006 with a mission to combine his search expertise with nonprofit board experience, David Martin now leads a highly experienced, diverse team of 15, combining in-depth client analysis with the latest search technologies to create effective, personalized searches. Since the day he founded the firm, David has personally taken a leadership role with every search, for every client.